Anja Rabenhorst

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.

Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.

Journal: Allergy

Published: January 14, 2016

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.

Journal: The Journal of allergy and clinical immunology

Published: June 19, 2015

Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity.

Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity.

Journal: The Journal of allergy and clinical immunology

Published: March 31, 2015

Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.

Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.

Journal: Allergy

Published: March 18, 2015

Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells.

Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells.

Journal: Oncotarget

Published: December 19, 2014

Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.

Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.

Journal: The Journal of allergy and clinical immunology

Published: December 12, 2014

Cre/loxP-based mouse models of mast cell deficiency and mast cell-specific gene inactivation.

Cre/loxP-based mouse models of mast cell deficiency and mast cell-specific gene inactivation.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 13, 2014

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.

Journal: Oncotarget

Published: October 31, 2014

Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.

Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 29, 2014

Dicer is indispensable for the development of murine mast cells.

Dicer is indispensable for the development of murine mast cells.

Journal: The Journal of allergy and clinical immunology

Published: February 13, 2014

Interleukin-31: a novel diagnostic marker of allergic diseases.

Interleukin-31: a novel diagnostic marker of allergic diseases.

Journal: Current allergy and asthma reports

Published: February 11, 2014

Reply: To PMID 23910691.

Reply: To PMID 23910691.

Journal: The Journal of allergy and clinical immunology

Published: November 28, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026